Newsfeeds - Spark Newswire

2 minute read

OpGen Initiates Clinical Trial For Unyvero Urinary Tract Infection Panel

Today, 9:58 PM

OpGen, Inc. (NASDAQ:OPGN, &ldquo, OpGen&rdquo, )), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has initiated

OPGN

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 9:58 PM

Gainers

APRE

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 9:58 PM

Gainers

BNR

2 minute read

4 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 9:58 PM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ARC

1 minute read

OpGen Announces Data From Prospective Randomized Controlled Multicenter Clinical Study Using The Unyvero HPN Panel For Hospitalized Patients With Suspicion of Pneumonia

By Benzinga Newsdesk

Today, 9:58 PM

- Unyvero reduced the use of inappropriate antibiotic therapy by 45.1% - Unyvero shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.54% - 3

OPGN

3 minute read

22 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 9:58 PM

Gainers

ACRX

3 minute read

24 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 9:58 PM

Gainers

APOP

1 minute read

OpGen Q2 EPS $(0.19) Beats $(0.20) Estimate, Sales $800.00K Miss $1.12M Estimate

By Michael Horton

Today, 9:58 PM

OpGen (NASDAQ:OPGN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 61.22 percent increase over losses of $(0.49) per share from the same period

OPGN